Saitama Medical University · Faculty of Medicine / Graduate School of Medicine · 准教授

Research keywordsnon-small cell lung cancer・immune checkpoint inhibitors・post-progression survival・nivolumab・EGFR-TKI rechallenge・pembrolizumab・opioid-induced constipation・thymic carcinoma・carboplatin nausea control・PD-L1 high expression

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study
• Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis
• Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study
• Course of postoperative relapse in non-small cell lung cancer is strongly associated with post-progression survival

• Official profile
• ORCID